Judge nixes administration rule to require drug prices in TV ads

Article Image

A federal judge has nixed a regulation that was a centerpiece of the Trump administration's efforts to bring down drug prices.US District Judge Amit M...

Posted: Jul 9, 2019 3:33 AM

A federal judge has nixed a regulation that was a centerpiece of the Trump administration's efforts to bring down drug prices.

US District Judge Amit Mehta of the District of Columbia vacated Monday the Department of Health and Human Services' rule that would have required drug makers to include their list prices in TV ads, saying the agency had overstepped its authority. The rule had been set to go into effect Tuesday.

"No matter how vexing the problem of spiraling drug costs may be, HHS cannot do more than what Congress has authorized," Mehta wrote. "The responsibility rests with Congress to act in the first instance."

The lawsuit was filed in June by Merck, Eli Lilly, Amgen and the Association of National Advertisers, which said the rule would mislead patients about how much they have to pay for medication and that the department had exceeded its authority.

HHS said it was disappointed with the ruling and would work with the Department of Justice on next steps related to litigation.

"President Trump and Secretary Azar remain focused on lowering drug prices and empowering patients through more transparency in healthcare costs," said Caitlin Oakley, spokeswoman for the agency, referring to HHS Secretary Alex Azar.

Lowering drug prices has been a central focus of President Donald Trump, as well as lawmakers on both sides of the aisle. Experts, however, have questioned the usefulness of providing the list prices of medicine in ads, as most people with insurance pay far less. They fear that advertising list prices may scare patients away from drugs they could afford with their health insurance coverage.

Azar served as president of Lilly USA, the company's largest affiliate, before joining the Trump administration. He has since lambasted his former industry peers for high drug costs.

The rule, announced in May, was the first to be implemented from the administration's blueprint to lower drug costs, which was released in 2018. It mandates that drug makers include the price for any medication that costs more than $35 for a month's supply or the usual course of treatment. The agency picked that price because it's roughly the average copay for a preferred brand-name drug.

"Requiring the inclusion of drugs' list prices in TV ads is the single most significant step any administration has taken toward a simple commitment: American patients deserve to know the prices of the health care they receive," Azar said at the time.

While the new rule does not have an enforcement mechanism, Azar said failing to include the price would be considered a deceptive trade practice and could prompt lawsuits by industry rivals.

Article Comments

Medford
Overcast
48° wxIcon
Hi: 58° Lo: 44°
Feels Like: 48°
Brookings
Overcast
55° wxIcon
Hi: 55° Lo: 48°
Feels Like: 55°
Crater Lake
Overcast
43° wxIcon
Hi: 50° Lo: 35°
Feels Like: 39°
Grants Pass
Overcast
50° wxIcon
Hi: 62° Lo: 48°
Feels Like: 50°
Klamath Falls
Overcast
43° wxIcon
Hi: 51° Lo: 32°
Feels Like: 39°
Spotty Sunday Showers
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events

Latest Video

Image

National Drug Take Back Day

Image

Sunday, October 20 morning weather

Image

Southern Oregon gets past Eastern Oregon for third straight win

Image

Oregon State eclipses 2018 win total

Image

Oregon knocks off rival Washington

Image

Mass Casualty Incident Drill

Image

Saturday, October 19 morning weather

Image

Friday Night Blitz: Week 7 scores and highlights

Image

Eagle Point High School welcomes new sparrow

Image

Friday, October 18th Evening Weather